Ignite Creation Date:
2025-12-26 @ 10:57 AM
Ignite Modification Date:
2026-01-04 @ 9:01 AM
Study NCT ID:
NCT02873208
Status:
COMPLETED
Last Update Posted:
2021-07-21
First Post:
2016-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
Sponsor:
Alkermes, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-08-07
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-17
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-16
First Submit QC Date:
None
Study First Post Date:
2016-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-06-22
Results First Submit QC Date:
None
Results First Post Date:
2021-07-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-09-01
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-07-20
Last Update Post Date:
2021-07-21
Last Update Post Date Type:
ACTUAL